Carlos Lahoz Rallo

Hospital Carlos III - Madrid, Madrid, Madrid, Spain

Are you Carlos Lahoz Rallo?

Claim your profile

Publications (9)3.17 Total impact

  • Clínica e Investigación en Arteriosclerosis 03/2012;
  • Clínica e Investigación en Arteriosclerosis 11/2011;
  • [Show abstract] [Hide abstract]
    ABSTRACT: Introduction: Numerous studies have shown that statins reduce cardiovascular mortality. While most of the effect is probably due to their lipid-lowering action, other actions of these drugs, independent of cholesterol reduction, have been described that could influence these beneficial action. The aim of this study was to evaluate the effect of statins on the expression of adhesion molecules, cytokines and receptors of peripheral blood monocytes, cells closely linked to development of atherosclerosis. Patients and methods: We selected 22 patients with moderate hypercholesterolemia (59% female, mean age 51 years). After 6 weeks of a low fat they were randomized to receive 40 mg of pravastatin or placebo for 8 weeks. After that period they received for another 8 weeks the other treatment. Results: Treatment with pravastatin significantly reduced the concentration of total cholesterol (22%; p < 0.01) and LDL-cholesterol (30%; p < 0.01). Monocytic intracytoplasmic expression of TNFa was reduced by 17.3% (p = 0,03). Other cellular markers, CD62L, CD162, CD11a, CD11b, CD49d, CD54, MCP-1 and CCR2, did not change their expression. Conclusion: Treatment with pravastatin for 8 weeks in patients with moderate hypercholesterolemia induces a decline in the average intensity of fluorescence with which peripheral blood monocytes express TNFa without changing the expression of other adhesion molecules. Introducción: Numerosos estudios han demostrado que las estatinas reducen la mortalidad cardiovascular. Si bien la mayor parte del efecto es probablemente debido a su acción hipolipemiante, se han descrito otras acciones de estos fármacos, independientes de la reducción del colesterol, que podrían contribuir a este efecto beneficioso. El objetivo del presente estudio fue evaluar el efecto del tratamiento con estatinas sobre la expresión de moléculas de adhesión, citocinas y receptores celulares de monocitos de sangre periférica, células estrechamente ligadas al desarrollo de la arteriosclerosis. Pacientes y métodos: Se seleccionó a 22 pacientes con hipercolesterolemia moderada (59% mujeres, edad media 51 años). Tras seguir durante 6 semanas una dieta baja en grasas, se aleatorizaron a recibir 40 mg/día de pravastatina o placebo durante 8 semanas, tras lo cual recibieron durante otras 8 semanas el tratamiento contrario. Resultados: El tratamiento con pravastatina redujo de manera significativa, respecto al período placebo, la concentración de colesterol total (22%; p < 0,01) y el colesterol unido a lipoproteínas de baja densidad (30%; p < 0,01). La expressión intracitoplasmática monocitaria del factor de necrosis tumoral alfa (TNFa) se redujo en un 17,3% (p = 0,03). No se observaron modificaciones en la expresión de CD62L, CD162, CD11a, CD11b, CD49d, CD54, MCP-1 y CCR2. Conclusión: El tratamiento con pravastatina durante 8 semanas en pacientes con hipercolesterolemia moderada induce un descenso en la intensidad media de fluorescencia con la que los monocitos de sangre periférica expresan TNFa, sin modificar la expresión de otras moléculas de adhesión.
    Clínica e investigación en arteriosclerosis, ISSN 1578-187, Vol. 21, Nº. 2, 2009, pags. 45-50. 01/2009;
  • [Show abstract] [Hide abstract]
    ABSTRACT: To evaluate the understanding of patients receiving statins about the dietary and therapeutic measures taken to control their cholesterol and to relate this to the achievement of therapy objectives. Transversal, multi-centre study, conducted between March and November, 2004. Three-hundred seventy six primary care and specialist doctors from all over the country. A total of 2347 patients, with an average age of 59 (12) and 48% women, being treated with statins. Survey to evaluate understanding of lipid-lowering diet and pharmacological treatment. The percentage of patients achieving therapy objectives in line with ATP III guidelines was determined. Understanding of diet was adequate only for foods with negative effects on the concentration of cholesterol. Overall, understanding was better in the young, those with a higher level of education, those with hyperlipaemia originating in the family, those under treatment for longer, and in those attended in primary care or internal medicine clinics; it was worse in diabetic patients and in those with cardiovascular disease. Patients with more understanding of their treatment reached their therapy objectives to a greater extent. Patients receiving statins treatment have an adequate understanding of diet, but little information on pharmacological treatment. This understanding is associated with the achievement of therapy objectives.
    Atención Primaria 10/2007; 39(9):473-8. · 0.96 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective To evaluate the understanding of patients receiving statins about the dietary and therapeutic measures taken to control their cholesterol and to relate this to the achievement of therapy objectives. Design Transversal, multi-centre study, conducted between March and November, 2004. Setting Three-hundred seventy six primary care and specialist doctors from all over the country. Participants A total of 2347 patients, with an average age of 59 (12) and 48% women, being treated with statins. Method Survey to evaluate understanding of lipid-lowering diet and pharmacological treatment. The percentage of patients achieving therapy objectives in line with ATP III guidelines was determined. Results Understanding of diet was adequate only for foods with negative effects on the concentration of cholesterol. Overall, understanding was better in the young, those with a higher level of education, those with hyperlipaemia originating in the family, those under treatment for longer, and in those attended in primary care or internal medicine clinics; it was worse in diabetic patients and in those with cardiovascular disease. Patients with more understanding of their treatment reached their therapy objectives to a greater extent. Conclusion Patients receiving statins treatment have an adequate understanding of diet, but little information on pharmacological treatment. This understanding is associated with the achievement of therapy objectives.
    Atencion Primaria - ATEN PRIM. 01/2007; 39(9):473-478.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Evaluate the overall achievement of goals in the control of risk factors in secondary prevention in patients who have suffered a coronary event and are followed up in primary care centers. Descriptive, transversal, multicenter study with sampling by consecutive inclusion of the first 5 patients attending the doctor's office who had suffered a coronary event 6 months to 10 years previously. The targets for control were: blood pressure < 140/90 mmHg in the general population and < 130/85 mmHg in diabetics; LDL-cholesterol < 100 mg/dl and no smoking habit. 8,817 patients (73.7% males) were included, with a mean (SD) age of 65.4 (10.3) years; 76.6% were hypertensive, 73.4% dyslipidemic and 32.7% diabetics; 60.2% achieved target blood pressure; 26.3% achieved LDL-cholesterol <100 mg/dl and 11.4% continued smoking; 16.4% fulfilled all recommendations. Factors independently related with good control were a lower age, male sex, patients who had been admitted with acute coronary syndrome without ST elevation (OR = 1.39; CI 95%, 1.01-1.93; p = 0.04) or for revascularization (OR = 1.37; CI 95%; 1.12-1.67; p = 0.002), patients with peripheral arterial disease (OR = 1.43; CI 95%, 1.11-1.84; p = 0.005) and when the physicians proposed suitable objectives (OR = 1.90; CI 95%, 1.48-2.44; p < 0.0001). Control was poorer in hypertensive or dyslipidemic patients. Overall control of risk factors in secondary prevention of coronary disease is achieved in one in six patients attending primary care.
    Medicina Clínica 12/2006; 127(20):765-9. · 1.25 Impact Factor
  • Atención Primaria 11/2006; 38(6):358-61. · 0.96 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background and objective Evaluate the overall achievement of goals in the control of risk factors in secondary prevention in patients who have suffered a coronary event and are followed up in primary care centers. Patients and method Descriptive, transversal, multicenter study with sampling by consecutive inclusion of the first 5 patients attending the doctor's office who had suffered a coronary event 6 months to 10 years previously. The targets for control were: blood pressure < 140/90 mmHg in the general population and < 130/85 mmHg in diabetics; LDL-cholesterol < 100 mg/dl and no smoking habit. Results 8,817 patients (73.7% males) were included, with a mean (SD) age of 65.4 (10.3) years; 76.6% were hypertensive, 73.4% dyslipidemic and 32.7% diabetics; 60.2% achieved target blood pressure; 26.3% achieved LDL-cholesterol <100 mg/dl and 11.4% continued smoking; 16.4% fulfilled all recommendations. Factors independently related with good control were a lower age, male sex, patients who had been admitted with acute coronary syndrome without ST elevation (OR = 1.39; CI 95%, 1.01-1.93; p = 0.04) or for revascularization (OR = 1.37; CI 95%; 1.12-1.67; p = 0.002), patients with peripheral arterial disease (OR = 1.43; CI 95%, 1.11-1.84; p = 0.005) and when the physicians proposed suitable objectives (OR = 1.90; CI 95%, 1.48-2.44; p < 0.0001). Control was poorer in hypertensive or dyslipidemic patients. Conclusions Overall control of risk factors in secondary prevention of coronary disease is achieved in one in six patients attending primary care.
    Medicina Clinica - MED CLIN. 01/2006; 127(20):765-769.
  • Atencion Primaria - ATEN PRIM. 01/2006; 38(6):358-361.